PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024

    Date:

    Profound Medical (NASDAQ:PROF) just reported results for the second quarter of 2024.

    • Profound Medical reported earnings per share of -28 cents. This was above the analyst estimate for EPS of -29 cents.
    • The company reported revenue of $2.23 million.
    • This was 13.78% worse than the analyst estimate for revenue of $2.59 million.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    All Tariff News is Now Good News

    Today is certainly a “rip up the script” sort...

    Forecast Contract Opinions for Tomorrow’s Expirations: May 12, 2025

    Your Privacy When you visit any website it may use...

    From Logistic to Random Forests: Mastering Non-linear Regression Models

    The post “From Logistic to Random Forests: Mastering Non-linear...